Research abstract

Resources abstract


Nature Biotechnology 26, 343 - 351 (2008)
Published online: 24 February 2008 | Corrected online: 8 July 2008 | doi:10.1038/nbt1387



There is a Corrigendum (July 2008) associated with this Resources.

Large-scale chemical dissection of mitochondrial function

Bridget K Wagner1,5, Toshimori Kitami1,2,5, Tamara J Gilbert1, David Peck1, Arvind Ramanathan1, Stuart L Schreiber1, Todd R Golub1,3 & Vamsi K Mootha1,2,4


Mitochondrial oxidative phosphorylation (OXPHOS) is under the control of both mitochondrial (mtDNA) and nuclear genomes and is central to energy homeostasis. To investigate how its function and regulation are integrated within cells, we systematically combined four cell-based assays of OXPHOS physiology with multiplexed measurements of nuclear and mtDNA gene expression across 2,490 small-molecule perturbations in cultured muscle. Mining the resulting compendium revealed, first, that protein synthesis inhibitors can decouple coordination of nuclear and mtDNA transcription; second, that a subset of HMG-CoA reductase inhibitors, combined with propranolol, can cause mitochondrial toxicity, yielding potential clues about the etiology of statin myopathy; and, third, that structurally diverse microtubule inhibitors stimulate OXPHOS transcription while suppressing reactive oxygen species, via a transcriptional mechanism involving PGC-1alpha and ERRalpha, and thus may be useful in treating age-associated degenerative disorders. Our screening compendium can be used as a discovery tool both for understanding mitochondrial biology and toxicity and for identifying novel therapeutics.

Top
  1. Broad Institute of Massachusetts Institute of Technology and Harvard, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA.
  2. Center for Human Genetic Research, Massachusetts General Hospital, 185 Cambridge Street, Boston, Massachusetts 02114, USA.
  3. Department of Pediatric Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA.
  4. Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02446, USA.
  5. These authors contributed equally to this work.

Correspondence to: Vamsi K Mootha1,2,4 e-mail: vamsi@hms.harvard.edu

* In the version of this article initially published, on p.348, column 2, paragraph 2, line 7, the following sentence was incorrect: "Statins block the synthesis of cholesterol—a precursor to ubiquinone...." It should have read "Statins block the synthesis of mevalonate, a precursor not only of cholesterol but also ubiquinone, ...." The error has been corrected in the HTML and PDF versions of the article.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

A toolkit for the cell's powerhouse

Nature Biotechnology News and Views (01 Mar 2008)


Extra navigation

Open Innovation Challenges

naturejobs

ADVERTISEMENT